The move comes shortly after the drugmaker filed a lawsuit claiming that previous coveragerestrictions by the Georgia Department of Community Health contributed to its financial problems and reflected the fallout of a larger dispute with the FDA over the medication.
The heart of the changes show an emphasis on preventive services, end-of-life conversations, prescription drug coverage, insurance company restrictions, with little focus on how this will all effect your doctor, accessibility of services, or your premiums.